Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
about
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers.Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors.Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
P2860
Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@en
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@nl
type
label
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@en
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@nl
prefLabel
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@en
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@nl
P2093
P2860
P356
P1433
P1476
Prediction of BRCA1 germ-line ...... , Lys27H3, vimentin, and KI67.
@en
P2093
Catherine Nogues
Dominique Petrot
François Eisinger
Hagay Sobol
Helene Dreyfus
Jean Marc Extra
Jean Philippe Peyrat
Jeanine Geneix
Jocelyne Jacquemier
Laetitia Huiart
P2860
P304
P356
10.1159/000339432
P577
2013-04-23T00:00:00Z